Archive · 14 Aug 2025
Glenmark Pharma Q1: Profit Plunges, Revenue Stable
Glenmark Pharma announced its financial results.
The company's profit decreased significantly.
The company's earnings before certain costs also went down a bit.
However, the company's sales remained stable.
The company's stock price slightly increased after the report.
Glenmark Pharma's net profit decreased to ₹47 crore.
Revenue remained stable.
EBITDA dipped 1.4% to ₹580 crore.
The EBITDA margin was lower at 17.7%.
Shares of Glenmark Pharmaceuticals Ltd. ended up 0.35%.
- Who
- Glenmark Pharmaceuticals Ltd.
- What
- Glenmark Pharma announced its Q1 earnings.
- When
- Q1
- Where
- Not specified
- Why
- Mixed financial results
- Net Profit
- ₹47 crore
- EBITDA
- ₹580 crore
- EBITDA Margin
- 17.7%
- Share Price Change
- 0.35%
